A whole genome screen for association with multiple sclerosis in Portuguese patients
Mònica Santos(University of Coimbra), Patrı́cia Maciel(United Nations University), Efrosini Setakis(MRC Biostatistics Unit), María José Sá(Fernando Pessoa University), Jorge Pinto‐Basto(Centogene (Germany)), José Figueiredo(Universidade Federal do Rio de Janeiro), José Dinis(IPO Porto), Stephen Sawcer(University of Cambridge), Alcides Victor Oliveira Sá, Alastair Compston(University of Cambridge), I. Coelho(Hospital da Senhora da Oliveira Guimarães), M. E. Rio(Hospital de São João), L Bigotte de Almeida(Hospital Garcia de Orta), Aline F. Valença(Portuguese Air Force Academy), Jorge Sequeiros(Universidade do Porto)
Cited by 16
Related Papers
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
|Nature Genetics|2013|1.5k
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy
|Nature Genetics|2020|1.3k